OBJECTIVES: To examine the relationship between influenza and activity of daily living (ADL) decline and other clinical indicators in nursing home (NH) residents. DESIGN: Retrospective NH-aggregated longitudinal study. SETTING: Two thousand three hundred fifty-one NHs in 122 U.S. cities from 1999 to 2005. PARTICIPANTS: Long-stay (>90 days) NH residents. MEASUREMENTS: Quarterly city-level influenza mortality and state-level influenza severity. Quarterly incidence of Minimum Data Set-derived ADL decline (≥ 4 points), weight loss, new or worsening pressure ulcers (PUs), and infections. Outcome variables chosen as clinical controls were antipsychotic use, restraint use, and persistent pain. RESULTS: City-level influenza mortality and state-level influenza severity were associated with higher rates of large (≥ 4 points) ADL decline (mortality β = 0.20, P < .001; severity β = 0.18, P < .001), weight loss (β = 0.19, P < .001; β = 0.24, P < .001), worsening PUs (β = 0.04, P = .08; β = 0.12, P < .001), and infections (β = 0.41, P < .001; β = 0.47, P < .001) but not with restraint use, antipsychotic use, or persistent pain. NH influenza vaccination rates were weakly associated with the outcomes (e.g., β = -0.009, P = .03 for ADL decline, β = 0.008, P = .07 for infections). Compared with the summer quarter of lowest influenza activity, the results for the other quarters translate to an additional 12,284 NH residents experiencing large ADL decline annually, 15,168 experiencing significant weight loss, 6,284 new or worsening PUs, and 29,753 experiencing infections due to influenza. CONCLUSION: The results suggest a substantial and potentially costly effect of influenza on NH residents. The effect of influenza vaccination on preventing further ADL decline and other clinical outcomes in NH residents should be studied further.
OBJECTIVES: To examine the relationship between influenza and activity of daily living (ADL) decline and other clinical indicators in nursing home (NH) residents. DESIGN: Retrospective NH-aggregated longitudinal study. SETTING: Two thousand three hundred fifty-one NHs in 122 U.S. cities from 1999 to 2005. PARTICIPANTS: Long-stay (>90 days) NH residents. MEASUREMENTS: Quarterly city-level influenza mortality and state-level influenza severity. Quarterly incidence of Minimum Data Set-derived ADL decline (≥ 4 points), weight loss, new or worsening pressure ulcers (PUs), and infections. Outcome variables chosen as clinical controls were antipsychotic use, restraint use, and persistent pain. RESULTS: City-level influenza mortality and state-level influenza severity were associated with higher rates of large (≥ 4 points) ADL decline (mortality β = 0.20, P < .001; severity β = 0.18, P < .001), weight loss (β = 0.19, P < .001; β = 0.24, P < .001), worsening PUs (β = 0.04, P = .08; β = 0.12, P < .001), and infections (β = 0.41, P < .001; β = 0.47, P < .001) but not with restraint use, antipsychotic use, or persistent pain. NH influenza vaccination rates were weakly associated with the outcomes (e.g., β = -0.009, P = .03 for ADL decline, β = 0.008, P = .07 for infections). Compared with the summer quarter of lowest influenza activity, the results for the other quarters translate to an additional 12,284 NH residents experiencing large ADL decline annually, 15,168 experiencing significant weight loss, 6,284 new or worsening PUs, and 29,753 experiencing infections due to influenza. CONCLUSION: The results suggest a substantial and potentially costly effect of influenza on NH residents. The effect of influenza vaccination on preventing further ADL decline and other clinical outcomes in NH residents should be studied further.
Authors: M Snowden; W McCormick; J Russo; D Srebnik; K Comtois; J Bowen; L Teri; E B Larson Journal: J Am Geriatr Soc Date: 1999-08 Impact factor: 5.562
Authors: Lisa A Jackson; Jennifer C Nelson; Patti Benson; Kathleen M Neuzil; Robert J Reid; Bruce M Psaty; Susan R Heckbert; Eric B Larson; Noel S Weiss Journal: Int J Epidemiol Date: 2005-12-20 Impact factor: 7.196
Authors: Kevin P High; Suzanne Bradley; Mark Loeb; Robert Palmer; Vincent Quagliarello; Thomas Yoshikawa Journal: Clin Infect Dis Date: 2004-12-06 Impact factor: 9.079
Authors: Andrea Gruneir; Jeff C Kwong; Michael A Campitelli; Alice Newman; Geoffrey M Anderson; Paula A Rochon; Vincent Mor Journal: Am J Public Health Date: 2013-12-12 Impact factor: 9.308
Authors: Chad R Straight; Olivia R Ringham; Jenna M Bartley; Spencer R Keilich; George A Kuchel; Laura Haynes; Mark S Miller Journal: J Gerontol A Biol Sci Med Sci Date: 2020-11-13 Impact factor: 6.053
Authors: Latarsha Chisholm; Robert Weech-Maldonado; Alex Laberge; Feng-Chang Lin; Kathryn Hyer Journal: Health Serv Res Date: 2013-06-26 Impact factor: 3.402
Authors: M Fraenkel; M Yitshak-Sade; L Beacher; M Carmeli; M Mandelboim; E Siris; V Novack Journal: Osteoporos Int Date: 2017-05-23 Impact factor: 4.507
Authors: Elliott Bosco; Robertus van Aalst; Kevin W McConeghy; Joe Silva; Patience Moyo; Melissa N Eliot; Ayman Chit; Stefan Gravenstein; Andrew R Zullo Journal: JAMA Netw Open Date: 2021-06-01